Boston-based venture capital firm Seae Ventures has launched a $107 million fund to invest in women and Black, Indigenous and other historically marginalized entrepreneurs who are developing health and financial technologies that benefit traditionally underrepresented populations. AHA is investing in the fund as part of its health equity investing strategy. 

“Hospitals and health systems have a vital role to play in building more equitable communities, but they can’t do it alone,” said AHA President and CEO Rick Pollack. “The American Hospital Association is excited to support partners like Seae Ventures that invest in health care technology companies and entrepreneurs who are too often left out of early financing. These investments will both tackle health inequity and create meaningful economic opportunity.” 

AHA also has invested in two other funds that finance historically marginalized entrepreneurs: Jumpstart Nova, which invests exclusively in Black-founded and -led startups focused on improving health care access and affordability; and SteelSky Ventures, a female-led venture capital firm focused on improving health outcomes for women.  
 

Related News Articles

Headline
The FBI, Cybersecurity and Infrastructure Security Agency and Australian Cyber Security Centre June 4 released an advisory on updated actions and tactics used…
Headline
The National Security Agency, Cybersecurity and Infrastructure Security Agency and international partners May 22 released guidance on securing data used for…
Headline
The FBI, along with the National Security Agency and other international cybersecurity agencies, this week released a joint agency advisory on cyber operations…
Headline
The FBI's Internet Crime Complaint Center released an alert May 7 warning of cyber actors exploiting vulnerabilities in end-of-life routers. Routers dated 2010…
Headline
The FBI’s Internet Criminal Complaint Center May 15 released an alert warning of a malicious text and voice messaging campaign involving impersonators…
Headline
The Administration for Strategic Preparedness and Response May 15 announced it is launching four pharmaceutical manufacturing projects using artificial…